As a novel oncogene, CIRBP has been shown to increase the expression of HIF-1α by binding to the 3′-UTR of its mRNA, which suppresses the expression of prostaglandin I synthase (PTGIS) and regulates tumor progression (Lu et al., 2018). The gene discussed is PTGIS; the disease is neoplasm.